The benefits of smoking in skin diseases

Clinics in Dermatology

Volumn 16, Issue 5, 1998, Pages 641-647

  Wolf, Ronni ^a   Wolf, Danny ^b   Ruocco, Vincenzo ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; APHTHOUS ULCER; ARTICLE; CARCINOGENESIS; CIGARETTE SMOKING; HERPES SIMPLEX; HUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SKIN DISEASE; ULCERATIVE COLITIS;

EID: 0032157182     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(98)00050-9     Document Type: Review

References (107)

1. 1. Harries AD, Baird A, Rhodes J. Non-smoking: A feature of ulcerative colitis. BMJ Clin Res Ed 1982;284:706.
2. 2. Harries AD, Jones L, Heatley RV, et al. Smoking habits and inflammatory bowel disease: Effect on nutrition. BMJ Clin Res Ed 1982;284:1161.
3. 3. Gyde SN, Prior P, Taylor K, et al. Cigarette smoking, blood pressure, and ulcerative colitis. Gut 1982;24:A998.
4. 4. Jick H, Walker AM. Cigarette smoking and ulcerative colitis. N Engl J Med 1983;308:261-3.
5. 5. Hanauer SB, Silverstein MD, Evans AA, et al. A case-control study of smoking in inflammatory bowel disease compared to the irritable bowel syndrome. Clin Res 1984;32:233A.
6. 6. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1984; 19:824-30.
7. 7. Logan RFA, Edmond M, Somerville KW, et al. Smoking and ulcerative colitis. BMJ 1984;288:751-3.
8. 8. Calkins B, Lilienfeld A, Mendeloff A, et al. Smoking factors in ulcerative colitis and Crohn's disease in Baltimore. Am J Epidemiol 1984;120:498.
9. 9. Holdstock G, Savage D, Harman M, et al. Should patients with inflammatory bowel disease smoke? BMJ 1984;288:362.
10. 10. Thornton JR, Emmett PM, Heaton KW. Smoking, sugar, and inflammatory bowel disease. BMJ 1985;290:1786-7.
11. 11. Stermer E, Levy N, Heinrish I. Smoking, sugar, and inflammatory bowel disease. BMJ 1985;291:487.
12. 12. Porro GBN, Panza E. Smoking, sugar, and inflammatory bowel disease. BMJ Clin Res Ed 1985;291:971-2.
13. 13. Burns DG. Smoking in inflammatory bowel disease and the irritable bowel syndrome. S Afr Med J 1986;69:232-3.
14. 14. Vessey M, Jewel D, Smith A, et al. Chronic inflammatory bowel disease, cigarette smoking and use of oral contraceptives: Findings in a large cohort study of women of childbearing age. BMJ 1986;292:1101-3.
15. 15. Tobin MV, Logan RFA, Langman MJS, et al. Cigarette smoking and inflammatory bowel disease. Gastroenterology 1987;93:316-21.
16. 16. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1987; 22:1130-6.
17. 17. Franceschi S, Panza E, Lavecchia C, et al. Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 1987;125:445-52.
18. 18. Boyko EJ, Koepsell TD, Perera DR, et al. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987;316:707-10.
19. 19. Lindberg E, Tysk C, Andersson K, et al. Smoking and inflammatory bowel disease: A case control study. Gut 1988;29:352-7.
20. 20. Logan RFA, Kay CR. Oral contraception, smoking and inflammatory bowel disease-findings in the Royal College of General Practitioners' Oral Contraception study. Int J Epidemiol 1989;18:105-7.
21. 21. Sandier RS, Holland KL. Smoking and inflammatory bowel disease. Gastroenterology 1988;94:A398.
22. 22. Motley RJ, Rhodes J, Ford GA, et al. Time relationship between cessation of smoking and onset of ulcerative colitis. Digestion 1987;37:125-7.
23. 23. Lorusso D, Leo S, Mischiagna G, et al. Cigarette smoking and ulcerative colitis: A case control study. Hepatogastroenterology 1989;36:202-4.
24. 24. Persson PG, Ahlbom A, Hallers G. Inflammatory bowel disease and tobacco smoke: A case-control study. Gut 1990;31:1377-81.
25. 25. Benoni C, Nilsson A, Nived O. Smoking and inflammatory bowel disease: Comparison with systemic lupus erythematosus: A case-control study. Scand J Gastroenterol 1990;25:751-5.
26. 26. Samuelsson SM, Ekbom A, Zack M, et al. Risk factors for extensive ulcerative colitis and ulcerative proctitis: A population-based case-control study. Gut 1991;32:1526-30.
27. 27. Nakamura Y, Kobayashi M, Nagai M, et al. A case-control study of ulcerative colitis in Japan. J Clin Gastroenterol 1994;18:72-9.
28. 28. Nakamura Y, Labarthe DR. A case-control study of ulcerative colitis with relation to smoking habits and alcohol consumption in Japan. Am J Epidemiol 1994;140:902-10.
29. 29. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-5.
30. 30. Reif S, Klein I, Arber N, et al. Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. Gastroenterology 1995;108:1683-7.
31. 31. DeCastella H. Non-smoking: A feature of ulcerative colitis. BMJ Clin Res Ed 1982;284:1706.
32. 32. Rudra T, Motley RJ, Rhodes J. Does smoking improve colitis? Scand J Gastroenterol 1989;170 (Suppl):61-63.
33. 33. Lashner BA, Hanauer SB, Silverstein MD, Testing nicotine gum for ulcerative colitis patients: Experience with single-patient trials. Dig Dis Sci 1990;35:827-32.
34. 34. Srivastava ED, Russel MAH, Feyerabend C, et al. Transdermal nicotine in active colitis. Eur J Gastroenterol 1991; 3:815-8.
35. 35. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330: 811-5.
36. 36. Thomas GAO, Rhodes J, Mani V, et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995;332:988-92.
37. 37. Kanekura T, Usuki K, Kanzaki T. Nicotine for pyoderma gangrenosum (Letter). Lancet 1995;345:1058.
38. 38. Kanekura T, Kanzaki T. Successful treatment of pyoderma gangrenosum with nicotine chewing gum (Letter). J Dermatol 1995;22:704-5.
39. 39. Naguib SM, Lundin RD, Davies HJ. Relation of various epidemiologic factors to cervical cancer as determined by a screening program. Obstet Gynecol 1966;28:451-9.
40. 40. Thomas DB. An epidemiologic study of carcinoma in situ and squamous dysplasia of the uterine cervix. Am J Epidemiol 1973;98:10-28.
41. 41. Clarke EA, Hatcher J, McKrown-Eyssen GE, et al. Cervical dysplasia: Association with sexual behavior, smoking and oral contraceptive use? Am J Obstet Gynecol 1985; 151:612-6.
42. 42. Harris RWC, Brinton LA, Cowdell RH, et al. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer 1980;42:359-69.
43. 43. Trevanthan E, Layde P, Webster LA, et al. Cigarette smoking and dysplasia and carcinoma in situ of the uterine cervix. JAMA 1983;250:499-502.
44. 44. Clarke EA, Morgan RW, Newman AM. Smoking as a risk factor in cancer of the cervix: Additional evidence from a case-control study. Am J Epidemiol 1982;115:59-66.
45. 45. Nischan P, Ebling K, Schindler C. Smoking and invasive cervical cancer risk: Results from a case-control study. Am J Epidemiol 1988;128:74-77.
46. 46. La Vecchia C, Praceschi S, Decarli A, et al. Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol 1986;123:22-9.
47. 47. Winkelstein W Jr. Smoking and cervical cancer - current status: A review. Am J Epidemiol 1990;131:945-57.
48. 48. Halsey NA, Coberly JS, Holt E, et al. Sexual behavior, smoking, and HIV-1 infection in Haitian women. JAMA 1992;267:2062-66.
49. 49. Phillips AN, Smith GD. Smoking and human papillomavirus infection: Causal link not proved. BMJ 1993;306: 1268-9.
50. 50. Reducing the health consequences of smoking: 25 Years of progress, a report of the Surgeon General. Rockville, MD: Office on Smoking and Health; 1989.
51. 51. Tobacco smoking. Lyons, France. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC 1985;38:282-92.
52. 52. Nahmias AJ, Josey WE, Naib ZM, et al. Antibodies to herpes virus hominis type 1 and 2 in humans. Am J Epidemiol 1970;107:710-6.
53. 53. Nahmias AJ, Sawanabori S. The genital herpes-cervical cancer hypothesis-10 years later. Prog Exp Tumor Res 1978;21:117-39.
54. 54. Rawls WE, Clarke A, Smith KO, et al. Specific antibodies to herpes simplex virus type 2 among women with cervical cancer. In: Essex M, Todaro G, zur Hausen H, editors. Viruses in naturally occurring cancers (vol A). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1980:117-33.
55. 55. Graham S, Rawls WE, Swanson M, et al. Sex partners and herpes simplex virus type 2 in the epidemiology of cancer of the cervix, Am J Epidemiol 1982;115:729-35.
56. 56. Editorial: Herpes virus and cancer of uterine cervix. BMJ 1976;1(6011):671-2.
57. 57. Melnik JL, Dreesman GR, Adam E, et al. The role of herpes simplex virus in cervical and vulvar cancer. Dev Biol Stand 1982;52:87-94.
58. 58. Campione-Piccardo J. Analysis of world-wide age-specific data for the association of cervical cancer with infections by herpes simplex virus type 2. Med Hypotheses 1985;16:333-50.
59. 59. Kjaer SK, de Villiers EM, Haugaard BJ, et al. Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark: A population-based cross-sectional study. Int J Cancer 1988;41:518-24.
60. 60. Sabin AB, Tarro G. Herpes simplex and herpes genitalis viruses in etiology of some human cancer. Proc Natl Acad Sci USA 1973;70:3225-9.
61. 61. Hollinshead AC, Lee O, Chretien PB, et al. Antibodies to herpes virus nonvirion antigens in squamous carcinomas. Science 1973;182:713-5.
62. 62. Hollinshead AC, Chretien PB, Lee OV, et al. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens. Cancer Res 1976;36:821-8.
63. 63. Lehner T, Wilton JMA, Shillitoe EJ, et al. Cell-mediated immunity and antibodies to herpes virus hominis type 1 in oral leukoplakia and carcinoma. Br J Cancer 1973;27: 351-61.
64. 64. Shillitoe EJ, Greenspan D, Greenspan JS, et al. Neutralizing antibody to herpes simplex virus type 1 in patients with oral cancer. Cancer 1982;49:2315-20.
65. 65. Kumari TV, Vasudevan DM, Ankathil R, et al. Demonstration of HSV-1 antigen in patients with oral cancer by immunofluorescence and immunoperoxidase techniques. J Exp Pathol 1987;3:75-86.
66. 66. Mayberry RM. Cigarette smoking, herpes simplex virus type 2 infection, and cervical abnormalities. Am J Public Health 1985;75:676-8.
67. 67. Shillitoe EJ, Greenspan D, Greenspan JS, et al. Neutralizing antibody to herpes simplex virus type 1 in patients with oral cancer. Cancer 1982;49:2315-20.
68. 68. Smith HG, Horowitz N, Silverman NA, et al. Humoral immunity to herpes simplex viral-induced antigens in smokers. Cancer 1976;38:1155-62.
69. 69. Axéll T, Liedholm R. Occurrence of recurrent herpes labialis in an adult Swedish population. Acta Odontol Scan 1990;48:119-23.
70. 70. Zur Hausen H. Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet 1982;2:1370-2.
71. 71. Shillitoe EJ, Silverman S Jr. Oral cancer and herpes simplex virus - a review. Oral Surg 1979;48:216-24.
72. 72. Nahmias AJ, Norrild B. Oncogenic potential of herpes simplex viruses and their association with cervical neoplasia. In: Rapp F, editor. Oncogenic herpes viruses (vol 2). Boca Raton, FL: CRC Press, 1980: 25-45.
73. 73. Rapp F. Transformation by herpes simplex viruses. Cold Spring Harb Conf Cell Prolif 1980;7:63-80.
74. 74. Wentz WB, Reagan JW, Heggie AD. Experimental carcinoma of the uterine cervix with herpes-virus II. Obstet Gynecol 1975;46:117-21.
75. 75. Wentz WB, Reagan JW, Heggie AD, et al. Induction of uterine cancer with inactivated herpes simplex virus, types 1 and 2. Cancer 1981;48:1783-90.
76. 76. Burns JC, Murray BK. Conversion of herpetic lesions to malignancy by ultraviolet exposure and promotor application. J Gen Virol 1981;55:3051-13.
77. 77. Duff R, Rapp F. Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. J Virol 1971;8:469-77.
78. 78. Duff R, Rapp F. Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J Virol 1973;12:209-17.
79. 79. Bacchetti S, Graham F. Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA. Proc Natl Acad Sci USA 1977;74:1590-4.
80. 80. Li JL, Jerkofsky MA, Rapp F. Demonstration of oncogenic potential of mammalian cells transformed by DNA-containing viruses following photodynamic inactivation. Int J Cancer 1975;15:190-202.
81. 81. Rapp F, Shillitoe EJ. Transformation of non-lymphoid cells by herpes viruses: A review. IARC Sci Publ 1978; 24:431-50.
82. 82. Hirsch JM, Svennerholm B, Vahlne A. Inhibition of herpes simplex virus replication by tobacco extracts. Cancer Res 1984;44:1991-7.
83. 83. Park NH, Weiss RS, Sapp JP. In vitro and in vivo effect of smokeless tobacco on the replication of herpes simplex virus. J Dent Res 1985;64:266 (Abstract 826).
84. 84. Park NH, Sapp JP, Herbosa EG. Oral cancer induced in hamsters with herpes simplex infection and simulated snuff dipping. Oral Surg Oral Med Oral Pathol 1986;62: 164-8.
85. 85. Smoking and immunity. Lancet 1990;335:1561-3 (Editorial).
86. 86. US Department of Health and Human Services: The Health Benefits of Smoking Cessation. US DHHS, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health (DHHS Publication No. CDC 90-8416). Washington, DC: U.S. Government Printing Office.
87. 87. Mills CM, Hill SA, Marks R. Altered inflammatory responses in smokers. BMJ 1993;307:911-2.
88. 88. Wolf R, Lo Schiavo A, Ruocco V. Smoking out the skin. J Appl Cosmetol 1995;13:1-14.
89. 89. Smith JB, Fenske NA. Cutaneous manifestations and consequences of smoking. J Am Acad Dermatol 1996;34: 717-32.
90. 90. Baughman RD. Psoriasis and cigarettes. Another nail in the coffin. Arch Dermatol 1993;129:1329-30 (Editorial).
91. 91. Kavli G, Forde OH, Amesen E, et al. Psoriasis: Familial predisposition and environmental factors. BMJ 1985;291: 999-1000.
92. 92. Braathen LR, Botten G, Bjerkedal T. Psoriatics in Norway. Acta Derm Venereol Suppl (Stockh) 1989;142:9-12.
93. 93. Naldi L, Parazzini F, Brevi A, et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol 1992;127:212-7.
94. 94. O'Doherty CJ, Macintyre C. Palmoplantar pustulosis and smoking. BMJ 1985;291:861-4.
95. 95. Mills CM, Srivastava ED, Harvey IM, et al. Cigarette smoking is not a risk factor in atopic dermatitis. Int J Dermatol 1994;33:33-4.
96. 96. Edman B. Palmar eczema: A pathogenic role for acetyl-salicylic acid, contraceptives and smoking? Acta Derm Venereol 1988;68:402-7.
97. 97. Karvonen J, Poikolainen K, Rennald T, et al. Alcohol and smoking: Risk factors for infectious eczematoid dermatitis? Acta Derm Venereol 1992;72:208-10.
98. 98. Mills CM, Peters TJ, Finlay AY. Does smoking influence acne? Clin Exp Dermatol 1993;18:100-1.
99. 99. Bookman R. Relief of ulcer sores on resumption of cigarette smoking. Calif Med 1960;93:235-6.
100. 100. Dorsey C. More observations on relief of aphthous stomatitis on resumption of cigarette smoking. Calif Med 1963;101:377-8.
101. 101. Chellemi SJ, Olson DL, Shapiro S. The association between smoking and aphthous ulcers: A preliminary report. Oral Surg 1970;29:832-6.
102. 102. Shapiro S, Olson DL, Chellemi SJ. The association between smoking and aphthous ulcers. Oral Surg 1970;30: 624-30.
103. 103. Salonen L, Axéll T, Helldén L. Occurrence of oral lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. J Oral Pathol Med 1990;19:170-6.
104. 104. Axéll T, Henricsson V. Association between recurrent aphthous ulcers and tobacco habits. Scan J Dent Res 1985;93:239-42.
105. 105. Grady D, Ernster VL, Stillman L, et al. Smokeless tobacco use prevents aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1992;74:463-5.
106. 106. Bittoun R, Burke W. Aphthous ulcers and smoking cessation. Proceedings of the 7th World conference on Tobacco and Health, Perth, Australia, April 1-5, 1990;359 (monograph).
107. 107. Bittoun R. Recurrent aphthous ulcers and nicotine. Med J Austr 1991;154:471-2.